01_Taller SALUD: José Vicente Castell_ISS La Fe

33
SINERGIAS ENTRE EL SECTOR SANITARIO (HOSPITALARIO) Y EL EMPRESARIAL JOSE V. CASTELL PHD, MD DIRECTOR

description

 

Transcript of 01_Taller SALUD: José Vicente Castell_ISS La Fe

Page 1: 01_Taller SALUD: José Vicente Castell_ISS La Fe

SINERGIAS ENTRE EL SECTOR SANITARIO

(HOSPITALARIO) Y EL EMPRESARIALJOSE V. CASTELL PHD, MD

DIRECTOR

Page 2: 01_Taller SALUD: José Vicente Castell_ISS La Fe

UNIVERSITY HOSPITALS :

BIOMEDICAL RESEARCH

MEDICAL TRAINING

HEALTHCARE

Page 3: 01_Taller SALUD: José Vicente Castell_ISS La Fe

HIGHLY QUALIFIED PERSONNEL + ADVANCED TECHNOLOGIES

Page 4: 01_Taller SALUD: José Vicente Castell_ISS La Fe

GREAT INNOVATIVE POTENTIAL …

4

Page 7: 01_Taller SALUD: José Vicente Castell_ISS La Fe
Page 8: 01_Taller SALUD: José Vicente Castell_ISS La Fe

INNOVATION IN UNIVERSITY HOSPITALS

BIOMEDICAL RESEARCH

INNOVATIONMEDICAL TRAINING

HEALTHCARE

Page 9: 01_Taller SALUD: José Vicente Castell_ISS La Fe

INTEGRATING INNOVATION IN HOSPITAL ACTIVITY

Innovation is NOT a first priority in hospitals

Innovation should be integrated and be part of

the current activity of health professionals

Support structures should be implemented in

order to “extract” potential innovations out of

clinical knowledge

Page 10: 01_Taller SALUD: José Vicente Castell_ISS La Fe
Page 11: 01_Taller SALUD: José Vicente Castell_ISS La Fe
Page 13: 01_Taller SALUD: José Vicente Castell_ISS La Fe

Ideas / biomedical research

Strategic Validation Process

Prototypes – Proof of concept

Integration in healthcare practice

Successful

INNOVATION

is complex

Intellectual Property Rights IPRs

Clinical Validation

Commercialization

Feedback and improvement

Page 14: 01_Taller SALUD: José Vicente Castell_ISS La Fe

Idea / biomedical research

Strategic Validation Process

Prototype – Proof of concept

Diffusion and adoption in Healthcare

Intellectual Property Rights IPRs

Clinical Validation

Commercialization

Feedback and improvement

Successful

INNOVATION

is complex

Page 16: 01_Taller SALUD: José Vicente Castell_ISS La Fe

Idea Licencing-SME Valorization Commercialization

Large investments

not always affordable

Page 17: 01_Taller SALUD: José Vicente Castell_ISS La Fe
Page 18: 01_Taller SALUD: José Vicente Castell_ISS La Fe
Page 19: 01_Taller SALUD: José Vicente Castell_ISS La Fe
Page 21: 01_Taller SALUD: José Vicente Castell_ISS La Fe

Linking agents of the Science-

technology-Enterprise System, to

accelerate the process of

valorization, transferability and

the way to market in the field of

biomedical research

Hosting biomedical enterprises

Basic

Research

Clinical

Reseach

Valorization

and

Innovation

Transfer to

product

developers

Page 22: 01_Taller SALUD: José Vicente Castell_ISS La Fe

Biopole: 15.400 m2

Medical Faculty &

Management area:

13.500m2

Medical Care area: 166.400 m2

22

Page 25: 01_Taller SALUD: José Vicente Castell_ISS La Fe

CRUnit(biomedicalcontract

researchUnit )

Page 26: 01_Taller SALUD: José Vicente Castell_ISS La Fe

PLATFORMS

The IIS La Fe offers scientific and technological services with more than 10,000 m2 of clinical and research laboratories

CRUnit

Omic Platform

Genomics

Cytomics

Analitycal Unit

BiomedicalResearch Support

Pre-ClinicalToxicity Platform

Cell Culture Models

Animal Models

Clinical GeneticPlatform

Pharmacogenetics

CytogeneticAnalysis

Genetic Anlysis

Page 27: 01_Taller SALUD: José Vicente Castell_ISS La Fe

PRE-CLINICAL TOXICITY

PLATFORM

Cell Culture Models

[email protected]

Genotoxicity Hepatotoxicity Phototoxicity

Animal Models

[email protected]

Drug and Food Toxicity

Ecotoxicity

Coordinates preclinical or environmental studies in different levels of complexity from in vitro cellular models to animal models for a wide variety of toxicological studies.

The know-how and validated systems generated indoors are of great value in order to provide with

high quality experimental designs and accurate and reliable results promoting fast decision-making

Page 28: 01_Taller SALUD: José Vicente Castell_ISS La Fe

RESEARCH OMIC

PLATFORM

Genomics

[email protected]

Arrays

[email protected]

Genotiping and Sequencing

Cytogenetics

Cytomics

[email protected]

Analytical Unit

[email protected]

Metabolics/MS

Proteomics

It is a powerful platform for the analysis, validation

and interpretation of massive data sets

Merges a set of high-tech disciplines such as Genomics, Cytomics, Metabolomics and Proteomics.

Page 29: 01_Taller SALUD: José Vicente Castell_ISS La Fe

Offers a customised global GLPservice:

- including analytical services, - consultancy, as well as - the development of analytical methods

Request study

Tailoreddesign

Results in compliance

with regulation

Quick problem solvingFast-decision making

CUSTOMER NEEDS

Page 30: 01_Taller SALUD: José Vicente Castell_ISS La Fe

Enzymatic activities

Biomarkers

Metabolomic profile

Secondary metabolism compounds

Signal transduction

molecules

Target molecules from

biotransformation processes

Expertise and professionals at your disposal for a wide variety of analytical determinations in compliance with GLP principles:

Page 31: 01_Taller SALUD: José Vicente Castell_ISS La Fe

IDEA / PRODUCT

Stock Options or Shares, Capital return

Costs paid in valorization Procces

Page 33: 01_Taller SALUD: José Vicente Castell_ISS La Fe

www.iislafe.es